The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 548.20
Bid: 546.40
Ask: 546.60
Change: 13.20 (2.47%)
Spread: 0.20 (0.037%)
Open: 536.60
High: 548.20
Low: 536.20
Prev. Close: 535.00
BME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Management Succession and Board Update

15 Sep 2022 08:20

RNS Number : 5717Z
B&M European Value Retail S.A.
15 September 2022
 

 

 

15 September 2022

B&M European Value Retail S.A.

 

Management Succession and Board Update

 

 

B&M European Value Retail S.A. ("the Group"), the UK's leading variety goods value retailer, announced on 31 May 2022 that Alex Russo (currently Group Chief Financial Officer "CFO") would succeed Simon Arora as Group Chief Executive Officer ("CEO"). The Group today confirms that Alex will become CEO on 26 September 2022, the commencement of the second half of the Group's financial year. At that point Simon Arora, who announced his intention to step down as CEO on 22 April 2022, will retire as CEO but continue to serve the Board as an Executive Director until the end of his notice period in April 2023.

 

Mike Schmidt, who was previously announced as the successor to Alex Russo in the role of CFO, will join the business on 17 October 2022. In the short period between Alex's appointment as CEO taking effect on 26 September 2022 and Mike joining as CFO on 17 October 2022, Alex will retain responsibility for his current role and will be supported in that work by Peter Waterhouse as Group Financial Controller.

 

On 18 August 2022, the Group announced that Ron McMillan (currently Senior Independent Director and Chair of the Audit and Risk Committee) would be retiring as a Director at the conclusion of the Company's AGM in July 2023 and that Oliver Tant would be appointed to the Board in November 2022 and would succeed Ron as Chair of the Audit and Risk Committee when he retires from the Board. The Group now confirms that Tiffany Hall, currently Non-Executive Director and Chair of the Remuneration Committee, will become Senior Independent Director when Ron retires from the Board.

 

Since there is currently no vacancy in the office of a Director, in accordance with Luxembourg law, Mike Schmidt's and Oliver Tant's appointments to the Board are required to be approved by resolutions of shareholders at a general meeting of the Company. Accordingly, an Ordinary General Meeting of shareholders will be convened for 31 October 2022 (the "Meeting") for that purpose. Subject to their appointments being approved at the Meeting, both appointments to the Board will take effect on 1 November 2022. Further announcements will be made to confirm when the notice of the Meeting has been sent to shareholders and, following the Meeting, to confirm the outcomes of the votes.

 

This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation. There is no further information to be disclosed in accordance with Listing Rule 9.6.13.

 

B&M European Value Retail S.A.

For further information please contact +44 (0) 151 728 5400 ext. 5763

Simon Arora, Chief Executive

Alex Russo, Chief Financial Officer

Investor.relations@bandmretail.com

 

Media

For media please contact +44 (0) 207 379 5151

Sam Cartwright, Maitland

bmstores-maitland@maitland.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOALAMFTMTBBMLT
Date   Source Headline
18th Jul 202311:00 amRNSBlock Listing Application
13th Jul 20231:46 pmRNSBlock listing Interim Review
30th Jun 20239:00 amRNSTotal Voting Rights
29th Jun 20237:00 amRNSQ1 FY24 Trading update
20th Jun 202310:01 amRNSBoard Appointment
20th Jun 20238:30 amRNSNotice of FY24 First Quarter Trading Statement
19th Jun 20237:00 amRNSAnnual Financial Report and Notices of AGM and EGM
13th Jun 20234:03 pmRNSDirector/PDMR Shareholding
31st May 20237:05 amRNSRetirement of Director after AGM
31st May 20237:00 amRNSFY23 Preliminary Results
22nd May 20236:08 pmRNSTR1- Notification of major holdings
21st Apr 202310:35 amRNSBoard Change
17th Apr 20234:28 pmRNSTiming of Preliminary Results Announcement
3rd Apr 20233:00 pmRNSNotice to Noteholders
3rd Apr 20232:59 pmRNSBank Facility Extension
16th Feb 20235:37 pmRNSPDMR Share Purchase
13th Jan 20231:09 pmRNSBlock listing Interim Review
11th Jan 20233:46 pmRNSDirector Dealing: Purchase of Bonds
10th Jan 20233:23 pmRNSDirector/PDMR Shareholding
5th Jan 20237:00 amRNSStrong Q3 FY23 Trading
14th Dec 20221:59 pmRNSDirector Dealing: Purchase of Bonds
9th Dec 202211:43 amRNSNotice of FY23 Third Quarter Trading Statement
18th Nov 20229:14 amRNSDirector/PDMR Shareholding
10th Nov 20227:00 amRNSHalf-year Report
2nd Nov 202212:06 pmRNSConfirmation of timing of Interim Results
31st Oct 20229:23 amRNSAppointment of directors- Result of Meeting
18th Oct 20223:51 pmRNSHolding(s) in Company
30th Sep 20227:00 amRNSTotal Voting Rights
27th Sep 20227:00 amRNSNotice of GM
15th Sep 20228:20 amRNSManagement Succession and Board Update
9th Sep 20222:17 pmRNSDirector/PDMR Shareholding
31st Aug 20223:06 pmRNSDirector/PDMR Shareholding
31st Aug 20223:01 pmRNSTotal Voting Rights
18th Aug 20227:00 amRNSBoard Appointment and Retirement
5th Aug 20224:41 pmRNSDirector/PDMR Shareholding
4th Aug 20227:00 amRNSAppointment of Joint Corporate Broker
3rd Aug 202212:12 pmRNSTR1 Notification
29th Jul 202210:28 amRNSAGM Voting Results
14th Jul 202212:07 pmRNSBlock Listing Application
13th Jul 20223:48 pmRNSBlock listing Interim Review
5th Jul 20227:00 amRNSBoard appointment
29th Jun 20227:00 amRNSQ1 FY23 Trading Update
21st Jun 20227:00 amRNSAnnual Financial Report and Notice of AGM
16th Jun 20229:55 amRNSHolding(s) in Company
9th Jun 20221:17 pmRNSHolding(s) in Company
9th Jun 202212:16 pmRNSDirector/PDMR grant of options
8th Jun 20227:00 amRNSDirector/PDMR Notice
31st May 20227:01 amRNSFY22 Preliminary Results
31st May 20227:00 amRNSCEO Succession
22nd Apr 20227:00 amRNSCEO Succession Plan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.